Skip to main content

Rockefeller Capital Management L.P.

Position in NVO — Novo Nordisk A S

CIK 1739439 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$75,095,658
+$22,430,227 QoQ
Shares Held
1,566,451
+9.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#43
of 1,341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 56% Shared 0% None 44%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $1,983,048,474 across 16 Drug Manufacturers - General names. NVO ranks #7 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
1,566,451 $75,095,658

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,095,658 1,566,451
2026-03-31 $52,665,431 1,433,073
2025-12-31 $68,222,853 1,340,858
2025-09-30 $41,982,789 756,583
2025-06-30 $28,519,269 413,203
2025-03-31 $45,731,933 658,582
2024-12-31 $42,809,313 497,667
2024-09-30 $57,699,653 484,586
2024-06-30 $79,334,891 555,800
2024-03-31 $73,853,752 575,185
2023-12-31 $53,709,894 519,187
2023-09-30 $46,900,484 515,730
2023-06-30 $37,739,078 233,202
2023-03-31 $35,783,264 224,854
2022-12-31 $33,693,433 248,954
2022-09-30 $23,508,892 235,962
2022-06-30 $26,984,445 242,165
2022-03-31 $28,484,101 256,498
2021-12-31 $25,057,536 223,728
2021-09-30 $22,786,723 237,337
2021-06-30 $18,317,314 218,662
2021-03-31 $10,545,430 156,414
2020-12-31 $7,648,155 109,494
2020-09-30 $5,953,899 85,754
2020-06-30 $5,377,937 82,131
2020-03-31 $5,175,634 85,974